← Eichor
Condition: Advanced Malignancy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Malignancy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT04332874Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE
Phase N/A · 12 location(s) · Pomeranian Medical University Szczecin · NCT06614790Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 · 8 location(s) · Ming-Yu Lien · NCT07039162Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
Phase 1 · 1 location(s) · Shanghai Pudong Hospital · NCT06501183Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06369259Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT05768503A Study of TIL in Advanced Solid Tumors (DFGD)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT06488950Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
Phase 2 · 2 location(s) · BeBetter Med Inc · NCT06706713Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1/Phase 2 · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06648096TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinom
Phase 2 · 14 location(s) · Centre Francois Baclesse · NCT04678362A Study of CM350 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Keymed Biosciences Co.Ltd · NCT05263960Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC
Phase 2 · 1 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT06969027A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
Phase 1/Phase 2 · 1 location(s) · CytosinLab Therapeutics Co., Ltd. · NCT06971523SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid T
Phase 1 · 11 location(s) · Qurgen Inc. · NCT06873659Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
NA · 2 location(s) · Xinqiao Hospital of Chongqing · NCT05754203Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06147960A Study of HS-20110 in Participants With Advanced Solid Tumors
Phase 1 · 8 location(s) · Hansoh BioMedical R&D Company · NCT06892379Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
Phase 1 · 3 location(s) · Adlai Nortye Biopharma Co., Ltd. · NCT07252479Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Phase 1/Phase 2 · 11 location(s) · Chipscreen Biosciences, Ltd. · NCT05271292ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
Phase N/A · 1 location(s) · Fang Wu · NCT05198154Toripalimab Combined With CAV/IE Regimen
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT04589741Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced
Phase 2 · 7 location(s) · Korea Institute of Oriental Medicine · NCT06249854Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer
NA · 1 location(s) · Shandong Cancer Hospital and Institute · NCT07408505Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemo
Phase 3 · 8 location(s) · Imunon · NCT06915025Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Pat
NA · 1 location(s) · Institut Claudius Regaud · NCT06797037A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
Phase 1/Phase 2 · 4 location(s) · Latticon Antibody Therapeutics, Inc · NCT06277219A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Dar
Phase N/A · 1 location(s) · Bayer · NCT07672119Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma
Phase 2 · 1 location(s) · West China Hospital · NCT06438822
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.